Abstract We found significant correlation between the incidence of severe influenza and Aspergillus antigenemia among medical intensive care unit patients for 7-month observation (coefficient g Z 0.976, p < 0.001). High-level ambient pollution was noticed for 2 months before the epidemic, highlighting that influenza patients might coinfect with aspergillosis in the community.
Introduction
Invasive pulmonary aspergillosis (IPA) was identified in 23e29% of critically ill patients with severe influenza A (H1N1)-related pneumonia. 1, 2 However, Martin-Loeches and Valles 3 raised the query of possible overdiagnosis based on Aspergillus galactomannan (GM) antigen in the serum of patients with severe influenza. Martin-Loeches et al 4 isolated Aspergillus spp. as a pathogen of hospitalacquired pneumonia in 8.7% of 46 critically ill influenza A (H1N1) patients, which indicates the study that assessed the effect of early corticosteroid therapy but was not intended to diagnose IPA for influenza patients. 4 The above studies mentioned prior corticosteroid use as a risk factor for IPA in severe influenza patients.
On the contrary, Garcia-Vidal et al 5 found that high numbers of fungal spores and subsequent circulating respiratory viruses, such as influenza A, in the ambient air increase the development of IPA 2e6 weeks later, suggesting that patients might acquire IPA outside the hospital. Nevertheless, they could not explain the reasons of increased environmental spores and did not mention the coexistence of IPA in the influenza patients. 5 In fact, influenza A viral infection might predispose the previously healthy patients to Aspergillus superinfection by suppression of cellular immunity. 6 Patients with unusually severe influenza might hint depressed T-cell function, thus becoming vulnerable to IPA. 7 Therefore, we postulate a transmission mode of previous exposure to environmental spores promoting IPA in severe influenza patients.
In Taiwan, an influenza epidemic peaked in February 2016, which caused chaotic situations to the health care facilities and record-breaking death toll in Taiwan (http:// www.chinapost.com.tw/taiwan/national/national-news/ 2016/03/09/460225/CDC-under.htm). To understand the incidence of IPA in severe influenza patients, we retrospectively reviewed the cases of severe influenza and positive Aspergillus GM antigen from the adult patients hospitalized in the medical intensive care units (ICUs) of two hospitals (A and B) in Tainan city, southern Taiwan, from August 1, 2015 through February 29, 2016. Hospital A is a tertiary referral medical center with 96 adult ICU beds. Hospital B is a regional cancer center with 63 adult ICU beds.
GM is a cell wall component released by Aspergillus spps. during active hyphal growth in tissues, thus detection of GM in blood reflecting a true Aspergillus infection rather than contamination from airway isolation. 8, 9 The Food and Drug Association of the United States has approved the use of Platelia Aspergillus enzyme immunoassay to detect GM in blood, which allows doctors to diagnose life-threatening aspergillosis sooner. The revised definitions for invasive fungal disease of the European Organization for Research and Treatment of Cancer/Mycosis Study Group (EORTC/ MSG) has accepted GM test as one of the microbiological criteria for diagnosing probable IPA. 10 Before the influenza epidemic, high-level atmospheric fine particulate matter (PM) with a diameter of 2.5 mm (designed PM 2.5 ) was frequently alarmed by Taiwan Air Quality Monitoring Network. High-level PM 2.5 would cause discomfort such as sore eyes, sore throat, or cough and people should consider reducing outdoor activity. Therefore, we reviewed levels of atmospheric PM as an index of ambient air pollution in Tainan city, which might contribute to increased environmental Aspergillus spores. 11 
Methods
A confirmed influenza case was defined as at least one positive assay for testing influenza, such as rapid influenza diagnostic tests, real time polymerase chain reaction (PCR), and viral isolation for specimens of nasopharyngeal swab and/or lower respiratory tract aspirates. Severe influenza was regarded as those influenza patients admitted to ICUs.
Aspergillus GM was detected using Platelia Aspergillus Ag assay (Bio-Rad Laboratories, Marnes-La-Coquette, France) in serum with a positive cut-off value of optical density index 0.5.
Data of PM 2.5 were obtained from Taiwan Air Quality Monitoring Network (http://taqm.epa.gov.tw/taqm/en/). Above high-level PM 2.5 concentrations were defined by an index of 54 mg/m 3 . The cumulative hours of above highlevel PM 2.5 per month was regarded as the exposure time of people to ambient air pollution.
Proportions were compared using the c2 test or Fisher's exact test. Pearson's correlation coefficient was used to determine the relationship between the incidences of severe influenza and Aspergillus antigenemia among the medical ICU patients. A p value < 0.05 indicated statistical significance (2-tailed test).
Results

Incidence of severe influenza and Aspergillus antigenemia
A total of 2712 hospitalized medical ICU patients (1640 in hospital A and 1072 in hospital B) were identified during the observed 7-month period. In February 2016, a total of 54 patients (32 in hospital A, 22 in hospital B) were diagnosed with severe influenza and 33 patients (24 in hospital A, 9 in hospital B) were positive for Aspergillus GM test (Table 1 ). The incidence trends of adult patients with severe influenza and/ or positive Aspergillus antigenemia in medical ICU patients were significantly increased in February 2016 compared with those in previous 6 months in both the hospitals (Table 1 and Figure 1A ). Furthermore, monthly incidences of Aspergillus antigenemia and severe influenza were highly positively correlated (Pearson's correlation coefficient g Z 0.976, p < 0.001; Figure 1B ). The number of noninfluenza patients with Aspergillus antigenemia significantly increased in hospital A and overall patients but did not increase significantly in hospital B during the influenza epidemic ( Table 1 ).
Types of influenza and patients with Aspergillus antigenemia
Among the total 54 severe influenza patients in February 2016, influenza A was identified in 45 patients, including 35 patients with influenza A(H1N1)pdm09 virus and 10 patients with influenza A virus different to (H1N1)pdm09 and H3N2. Meanwhile, 17 (31.5%) patients (12 in hospital A and 5 in hospital B) with severe influenza concurrently had Aspergillus antigenemia, which was tested on a mean of 8th day (4 patients 2 days) after admission ( 
Host factors risk for IPA
With respect to host factors, 10 (58.8%) of 17 patients with severe influenza and IPA received sepsis doses of hydrocortisone (>20 mg/day prednisone equivalent) for a mean of 5 days (range, 2e13 days) prior to GM testing. Of the remaining seven patients, six had immunomodulation comorbidities like prostate cancer, end-stage renal disease, decompensated liver cirrhosis, diabetes mellitus, and aplastic anemia ( Table 2 ). The only patient without steroid use and host risk factor was an 81-year-old woman with initial respiratory colonization of C. albicans and M. avium complex, also indicating the status of immunomodulation (Patient 1). The noninfluenza patients with IPA were almost hospitalized in medical ICUs, with vary underlying comorbidities, such as hematologic malignancies, solitary cancers, transplant recipients, and chronic obstructive pulmonary disorder. The surgical ICU patients rarely had IPA in the study period.
Clinical features of influenza with Aspergillus antigenemia
All 17 patients experienced worsening respiratory failure despite oesltamivir and extensive antibiotic therapy, thus requiring ventilator support. All had abnormal infiltrates on chest X-ray films, and 15 (88.2%) patients manifested with acute respiratory distress syndrome (ARDS). The overall mortality rate was 58.8%. Only four patients did not receive voriconazole therapy (Patients 3, 5, 6, and 13). Five of the seven survived patients required hospitalization for more than 8 weeks, also indicating severe morbidities (Table 2) .
Ambient air pollution
Monthly average of ambient air PM 10 in Taipei (northern Taiwan) was lower than that in Tainan and Kaohsiung (southern Taiwan), with significant correlation with PM 2.5 . The monthly average concentrations of PM 2.5 in winter were three times higher than those in summer in Tainan and Kaohsiung cities ( Table 1 ). Exposure of high-level PM 2.5 represented by cumulative hours of PM 2.5 54 mg/m 3 per month sharply increased within 2 months prior to the epidemic in Tainan city ( Figure 1A ). Hospital architectural construction/renovation
There were no works of architectural construction/renovation at hospitals A and B during the study period. Some architecture constructional works in hospital A started beyond the peak epidemic after March 1, 2016. Besides, the patients in hospital A with dual infections of influenza and IPA were hospitalized in four medical ICUs located at different floors (3F, 5F, 6F, and 8F) without specific predisposition to an environmental area.
Discussion
The EORTC/MSG host criteria were limited to severe immunodeficiency patients but not necessarily to critically ill influenza patients, 10 who, nonetheless, may develop IPA.
1,2
We found 17 severe influenza patients with Aspergillus antigenemia, who could be regarded as those with "probable" IPA, if host criteria were redefined in a more expanded way like immunomodulation. They had characteristics of: (1) low isolation rates of influenza virus and Aspergillus; (2) higher rate of ARDS and (3) higher proportion of non-H1N1 influenza than previous reports limited to influenza A (H1N1).
1e4
Atmospheric Aspergillus spores significantly increased in the high-ambient PM levels during the Asian sandstorm days in the influenza season at Tainan city. 11 Wu et al 11 confirmed increasing small Penicillium/Aspergillus particles (2e5 mm in diameter) from a mean of 246.93 spores/m 3 in background days to 974.58 spores/m 3 in sandstorm stays (p < 0.01). The lower humidity in sandstorm stays also increased the dispersion of spores in the air when intercontinental dust clouds were coming from China. Furthermore, the concentrations of ambient PM 10 , PM 2.5 , and influenza A virus were significantly higher during the Asian sandstorm days than during the background days in northern Taiwan. 12 The health effects of PM exposure on Taiwan people with subsequent influenza and IPA have not yet been determined. As four of our patients were positive for Aspergillus GM within 2 days of admission, they probably acquired Aspergillus and influenza infections outside the hospital. Besides, both the hospitals A and B did not conduct architectural construction/renovation during the study period. These findings might hint physicians to change clinical practice in testing GM as early as in the emergency room for unusually severe influenza patients.
In accordance with our proposed disease transmission model, modified from the description of Garcia-Vidal et al, 5 concurrent severe influenza and Aspergillus antigenemia developed after the exposure of people to above high-level PM 2.5 for more than 100 hours/month in previous 2 months in Tainan. The small Aspergillus spores in fine PM 2.5 air might go directly into the distal lung tissue and can penetrate into the gas-exchange region to cause angioinvasion, thus explaining the difficulty in isolating the Aspergillus from upper respiratory secretions, whereas GM could be detected in the blood. This theory might also explain the increasing GM detection in noninfluenza patients after PM exposure. They commonly had other immunocompromised status.
There were few limitations of the study. First, all the probable IPA patients did not undergo lung biopsy as concerning potential pneumothorax in the lung with ARDS. Second, the surveillance culture of environment was not performed. Further air sampling of fungus cultures at the ICUs of hospitals A and B might be conducted to clarify whether there would be possible confounding of environmental contamination or colonization.
In conclusion, we highlight a high-level PM exposure prior to influenza attack with increasing incidence of Aspergillus antigenemia. The causal relationship between PM 2.5 /PM 10 and patients with influenza/IPA remains weak. Nonetheless, a possible link with recent air pollution might hint physicians to list aspergillosis in the differential diagnosis of pneumonia for the severe influenza patients, especially with life-threatening ARDS, as suggested in a recent report. 13 
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